Source and traceability. Deutra 25 ppm is sourced from the Heavy Water Board under the Department of Atomic Energy, Government of India, and distributed through your local licensed pharmacy network. Every batch is independently re-verified at our food-grade bottling facility by isotope-ratio mass spectrometry to the 25 ppm ± 2 ppm clinical specification. Every unit dispensed carries a Certificate of Analysis with source lot traceability. Deutra is not a drug and does not require a prescription; it is offered as a complementary hydration option that patients may adopt in consultation with their treating physician.
This page is intended for medical professionals evaluating DDW for their patients. It contains a fuller technical and regulatory account than the patient-facing pages.
Mechanism of action — current understanding
The deuterium-depletion hypothesis centres on mitochondrial isotope effects in ATP synthase and other proton-translocating enzymes. Reduced cellular deuterium concentration is hypothesised to alter kinetic isotope effects favourably, with downstream effects on oxidative metabolism, redox status, and cell-cycle regulation in tumour cells. The hypothesis is supported by in-vitro and in-vivo data; mechanistic specifics remain an active area of investigation.
Clinical evidence summary
Phase 2 RCTs from Somlyai and colleagues in prostate, breast, and lung cancer have reported favourable trends in time-to-progression and quality-of-life endpoints. Sample sizes have been modest. Replication outside Hungary is limited. Indian clinical experience is currently observational and clinic-led.
Quality and characterisation
Deutra is manufactured by multi-stage fractional vacuum distillation. Every batch is characterised by isotope-ratio mass spectrometry; ppm is reported on the Certificate of Analysis (CoA) and matched to a batch ID. CoAs from the past 24 months are available on request to verifying physicians.
Drug-interaction data
No clinically significant interactions have been reported in the published literature, but the dataset is small. Please apply standard pharmacovigilance and document patient response.
Ordering for clinics
Clinics and hospitals can place purchase orders directly. Volume pricing, batch reservation, and bulk delivery are available. Contact: clinical@deutra.in.
Selected peer-reviewed research on DDW
The clinical literature on deuterium-depleted water remains modest in scale but has accumulated steadily since the early 1990s, principally from the group of Dr. Gábor Somlyai at HYD LLC. in Hungary, with international collaborators including Boros (UCLA), D’Agostino (USF), and Cascante (Barcelona). The complete library is at hyd.hu/en/publications.
Foundational
- Somlyai G et al. Naturally occurring deuterium is essential for the normal growth rate of cells. FEBS Letters 317, 1–4 (1993).
Mechanism — mitochondria, ATP synthase, isotope effects
- Boros LG, D’Agostino DP, Katz HE, Roth JP, Meuillet EJ, Somlyai G. Submolecular regulation of cell transformation by deuterium depleting water exchange reactions in the tricarboxylic acid substrate cycle. Medical Hypotheses 87, 69–74 (2016).
- Boros LG, Somlyai G, Collins TQ, Patel H, Beger RD. Serine Oxidation via Glycine Cleavage (SOGC) Continues its Emergence as a Hallmark of Defective Mitochondria. Cell Metabolism 23, 635–648 (2016).
- Kovács BZs, Puskás LG, Somlyai G et al. Blocking the Increase of Intracellular Deuterium Concentration Prevents the Expression of Cancer-Related Genes, Tumor Development, and Tumor Recurrence in Cancer Patients. Cancer Control 29, 1–11 (2022).
Oncology — clinical and observational
- Krempels K, Somlyai I, Somlyai G. A retrospective evaluation of the effects of deuterium-depleted water consumption on four patients with brain metastases from lung cancer. Integrative Cancer Therapies 7(3), 172–181 (2008).
- Gyöngyi Z, Budán F, Szabó I, Ember I, Kiss I, Krempels K, Somlyai I, Somlyai G. Deuterium Depleted Water Effects on Survival of Lung Cancer Patients and Expression of Kras, Bcl2 and Myc Genes in Mouse Lung. Nutrition and Cancer 65(2), 240–246 (2012).
- Krempels K, Somlyai I, Gyöngyi Z, Ember I, Balog K, Abonyi O, Somlyai G. A retrospective study of survival in breast cancer patients undergoing deuterium depletion in addition to conventional therapies. J. Cancer Research & Therapy 1(8), 194–200 (2013).
- Boros LG, Somlyai I, Kovács BZs, Puskás LG, Nagy LI, Dux L, Farkas Gy, Somlyai G. Deuterium Depletion Inhibits Cell Proliferation, RNA and Nuclear Membrane Turnover to Enhance Survival in Pancreatic Cancer. Cancer Control 28, 1–12 (2021).
- Somlyai G, Kovács BZs, Papp A, Somlyai I. A Preliminary Study Indicating Improvement in the Median Survival Time of Glioblastoma Multiforme Patients by the Application of Deuterium Depletion in Combination with Conventional Therapy. Biomedicines 11, 1989 (2023).
- Somlyai G, Papp A, Somlyai I, Kovács BZs, Debrődi M. Real-World Data Confirm That the Integration of Deuterium Depletion into Conventional Cancer Therapy Multiplies the Survival Probability of Patients. Biomedicines 13(4), 876 (2025).
Metabolic health
- Molnár M, Horváth K, Dankó T, Somlyai I, Kovács BZs, Somlyai G. Deuterium-depleted water stimulates GLUT4 translocation in the presence of insulin, which leads to decreased blood glucose concentration. Molecular and Cellular Biochemistry 476, 4507–4516 (2021). DOI: 10.1007/s11010-021-04231-0.
A note on clinical interpretation: the studies above are encouraging and important, but sample sizes have been modest, replication outside Hungary remains limited, and no regulatory authority anywhere has approved DDW as a treatment for cancer or any other disease. Deutra is supplied as a complementary, physician-guided water — never as a substitute for evidence-based therapy.